Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 22 studies | 32% ± 14% | |
astrocyte | 18 studies | 41% ± 19% | |
smooth muscle cell | 17 studies | 29% ± 11% | |
pericyte | 16 studies | 26% ± 11% | |
endothelial cell | 15 studies | 31% ± 12% | |
basal cell | 10 studies | 43% ± 22% | |
adipocyte | 10 studies | 46% ± 14% | |
epithelial cell | 9 studies | 47% ± 23% | |
ciliated cell | 9 studies | 34% ± 15% | |
type II pneumocyte | 9 studies | 41% ± 19% | |
type I pneumocyte | 8 studies | 35% ± 15% | |
myofibroblast cell | 6 studies | 32% ± 19% | |
club cell | 6 studies | 39% ± 14% | |
endothelial cell of lymphatic vessel | 6 studies | 28% ± 9% | |
cardiac muscle cell | 5 studies | 25% ± 4% | |
mesothelial cell | 5 studies | 32% ± 11% | |
abnormal cell | 4 studies | 33% ± 20% | |
retinal pigment epithelial cell | 4 studies | 41% ± 16% | |
endothelial cell of artery | 4 studies | 17% ± 1% | |
Mueller cell | 4 studies | 30% ± 10% | |
muscle cell | 4 studies | 29% ± 11% | |
connective tissue cell | 4 studies | 33% ± 10% | |
glial cell | 3 studies | 23% ± 7% | |
squamous epithelial cell | 3 studies | 44% ± 19% | |
endothelial cell of vascular tree | 3 studies | 25% ± 12% | |
cholangiocyte | 3 studies | 59% ± 11% | |
hepatocyte | 3 studies | 51% ± 30% | |
ependymal cell | 3 studies | 59% ± 15% | |
respiratory goblet cell | 3 studies | 43% ± 15% | |
transit amplifying cell | 3 studies | 44% ± 37% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 22% ± 7% | |
renal principal cell | 3 studies | 30% ± 11% | |
mucus secreting cell | 3 studies | 35% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 11145.27 | 180 / 180 | 100% | 84.76 | 429 / 430 |
lung | 100% | 9056.80 | 577 / 578 | 99% | 64.68 | 1146 / 1155 |
esophagus | 100% | 10233.96 | 1445 / 1445 | 99% | 78.92 | 181 / 183 |
intestine | 100% | 7222.16 | 965 / 966 | 99% | 55.07 | 521 / 527 |
prostate | 100% | 8215.98 | 245 / 245 | 99% | 52.98 | 495 / 502 |
stomach | 100% | 5482.11 | 359 / 359 | 98% | 61.62 | 280 / 286 |
bladder | 100% | 13164.90 | 21 / 21 | 98% | 58.51 | 492 / 504 |
uterus | 100% | 14008.04 | 170 / 170 | 97% | 111.32 | 447 / 459 |
breast | 100% | 8500.74 | 459 / 459 | 97% | 54.69 | 1083 / 1118 |
thymus | 100% | 8107.40 | 652 / 653 | 97% | 83.32 | 585 / 605 |
kidney | 100% | 5019.45 | 89 / 89 | 96% | 43.57 | 868 / 901 |
skin | 100% | 10654.28 | 1808 / 1809 | 95% | 52.10 | 448 / 472 |
liver | 92% | 3004.10 | 208 / 226 | 82% | 25.11 | 334 / 406 |
pancreas | 57% | 1357.92 | 187 / 328 | 94% | 52.17 | 168 / 178 |
adrenal gland | 100% | 5191.24 | 257 / 258 | 36% | 8.23 | 82 / 230 |
brain | 49% | 1215.89 | 1288 / 2642 | 79% | 24.47 | 557 / 705 |
adipose | 100% | 9480.07 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 19357.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.20 | 1 / 1 |
muscle | 99% | 4758.97 | 795 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 35.57 | 74 / 80 |
tonsil | 0% | 0 | 0 / 0 | 91% | 56.82 | 41 / 45 |
heart | 90% | 3968.71 | 775 / 861 | 0% | 0 | 0 / 0 |
spleen | 66% | 1563.32 | 159 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 1.84 | 4 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0050673 | Biological process | epithelial cell proliferation |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0035265 | Biological process | organ growth |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_1902018 | Biological process | negative regulation of cilium assembly |
GO_0048368 | Biological process | lateral mesoderm development |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0035329 | Biological process | hippo signaling |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0060045 | Biological process | positive regulation of cardiac muscle cell proliferation |
GO_0048339 | Biological process | paraxial mesoderm development |
GO_0060449 | Biological process | bud elongation involved in lung branching |
GO_0001829 | Biological process | trophectodermal cell differentiation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0006974 | Biological process | DNA damage response |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0001570 | Biological process | vasculogenesis |
GO_0061026 | Biological process | cardiac muscle tissue regeneration |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0071480 | Biological process | cellular response to gamma radiation |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0042060 | Biological process | wound healing |
GO_0030857 | Biological process | negative regulation of epithelial cell differentiation |
GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
GO_0072091 | Biological process | regulation of stem cell proliferation |
GO_0050679 | Biological process | positive regulation of epithelial cell proliferation |
GO_0070102 | Biological process | interleukin-6-mediated signaling pathway |
GO_0072307 | Biological process | regulation of metanephric nephron tubule epithelial cell differentiation |
GO_0060576 | Biological process | intestinal epithelial cell development |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0002067 | Biological process | glandular epithelial cell differentiation |
GO_1904036 | Biological process | negative regulation of epithelial cell apoptotic process |
GO_0003015 | Biological process | heart process |
GO_2000737 | Biological process | negative regulation of stem cell differentiation |
GO_1900182 | Biological process | positive regulation of protein localization to nucleus |
GO_2001237 | Biological process | negative regulation of extrinsic apoptotic signaling pathway |
GO_0003143 | Biological process | embryonic heart tube morphogenesis |
GO_1903703 | Biological process | enterocyte differentiation |
GO_0000902 | Biological process | cell morphogenesis |
GO_0050767 | Biological process | regulation of neurogenesis |
GO_0001894 | Biological process | tissue homeostasis |
GO_0045747 | Biological process | positive regulation of Notch signaling pathway |
GO_0010837 | Biological process | regulation of keratinocyte proliferation |
GO_0030903 | Biological process | notochord development |
GO_0060487 | Biological process | lung epithelial cell differentiation |
GO_0032570 | Biological process | response to progesterone |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0030859 | Biological process | polarized epithelial cell differentiation |
GO_0035019 | Biological process | somatic stem cell population maintenance |
GO_0140552 | Cellular component | TEAD-YAP complex |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005911 | Cellular component | cell-cell junction |
GO_0005829 | Cellular component | cytosol |
GO_0001674 | Cellular component | female germ cell nucleus |
GO_0005737 | Cellular component | cytoplasm |
GO_0030054 | Cellular component | cell junction |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0070064 | Molecular function | proline-rich region binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | YAP1 |
Protein name | Yes-associated protein isoform 9 Yes1 associated transcriptional regulator Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog) |
Synonyms | YAP65 |
Description | FUNCTION: Transcriptional regulator which can act both as a coactivator and a corepressor and is the critical downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis . The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ . Plays a key role in tissue tension and 3D tissue shape by regulating cortical actomyosin network formation. Acts via ARHGAP18, a Rho GTPase activating protein that suppresses F-actin polymerization . Plays a key role in controlling cell proliferation in response to cell contact. Phosphorylation of YAP1 by LATS1/2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration . The presence of TEAD transcription factors are required for it to stimulate gene expression, cell growth, anchorage-independent growth, and epithelial mesenchymal transition (EMT) induction . Suppresses ciliogenesis via acting as a transcriptional corepressor of the TEAD4 target genes AURKA and PLK1 . In conjunction with WWTR1, involved in the regulation of TGFB1-dependent SMAD2 and SMAD3 nuclear accumulation (By similarity). .; FUNCTION: [Isoform 2]: Activates the C-terminal fragment (CTF) of ERBB4 (isoform 3). .; FUNCTION: [Isoform 3]: Activates the C-terminal fragment (CTF) of ERBB4 (isoform 3). . |
Accessions | ENST00000282441.10 [P46937-1] ENST00000526343.5 [P46937-5] H0YCI3 ENST00000345877.6 [P46937-7] ENST00000629586.2 [P46937-3] P46937 ENST00000524575.5 [P46937-4] K0KVU2 ENST00000529029.1 ENST00000615667.4 [P46937-9] ENST00000537274.5 [P46937-8] ENST00000531439.5 [P46937-2] |